CROI 2026
The 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) was held in Denver, US, from 22 to 25 February.
-
22-25 February 2026
-
Denver, US
Top 5 stories on threats to the global HIV response from CROI 2026
Top 5 stories on HIV prevention and sexual health from CROI 2026
Top 5 stories on the search for an HIV cure from CROI 2026
Top 5 stories on the HIV response in Africa from CROI 2026
Top 5 stories on long-term health for people living with HIV from CROI 2026
The untapped potential of CD8 cells: how cellular immunity may be the key to an HIV cure
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable
Younger, mobile men especially likely to not know they have HIV in eastern and southern Africa
Can someone transmit HIV with a viral load of 200? Ugandan study re-ignites the U=U debate
Immune modulator N-803 does not control HIV rebound, suggesting a combination approach is needed for a functional cure
Multi-component app improves viral suppression in men who use crystal meth
New antiretrovirals in the pipeline could be part of twice-yearly HIV treatment
African paediatric studies at CROI: HIV remission in children, three bnAbs in babies, two years on injectables in teens
Vaccine fails to prevent gonorrhoea in Australian study
Broadly neutralising antibody plus cabotegravir maintains viral suppression for at least a year
Half the participants from placebo arm of HIV cure trial have prolonged viral load remission when given broadly neutralising antibodies
Major US cohort reveals sharp racial disparities in HIV acquisition among trans women